CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
PLoS One. 2013 Sep 27;8(9):e77031. doi: 10.1371/journal.pone.0077031. eCollection 2013.
We have examined the antimicrobial activity of C-terminal analogs of human β-defensins HBD-1 and-3 wherein lysines have been selectively replaced by L- and D-arginines and L-isoleucine substituted with its D-enantiomer. The analogs exhibited antibacterial and antifungal activities. Physiological concentration of NaCl did not attenuate the activity of the peptides against Gram-negative bacteria considerably, while some attenuation of activity was observed against S. aureus. Variable attenuation of activity was observed in the presence of Ca²⁺ and Mg²⁺. Introduction of D-amino acids abrogated the need for a disulfide bridge for exhibiting activity. Confocal images of carboxyfluorescein (CF) labeled peptides indicated initial localization on the membrane and subsequent translocation into the cell. Analogs corresponding to cationic rich segments of human defensins substituted with L- and D-arginine, could be attractive candidates for development as future therapeutic drugs.
我们研究了人源β防御素 HBD-1 和 HBD-3 的 C 末端类似物的抗菌活性,其中赖氨酸被选择性地替换为 L-和 D-精氨酸,L-异亮氨酸被其 D-对映体取代。这些类似物表现出抗菌和抗真菌活性。生理浓度的 NaCl 不会显著削弱这些肽对革兰氏阴性菌的活性,而对金黄色葡萄球菌的活性则有所减弱。在 Ca²⁺和 Mg²⁺存在下,活性会发生不同程度的减弱。引入 D-氨基酸可消除形成二硫键的必要性,从而发挥活性。CF 标记肽的共聚焦图像表明,这些肽最初定位于细胞膜上,随后进入细胞内。用 L-和 D-精氨酸取代人防御素中富含阳离子的片段的类似物,可能成为未来治疗药物开发的有吸引力的候选物。